Pharmacist's Letter Canada | Convenient Monthly Updates + CE

February 2026 Issue

Be Familiar With Tenecteplase for Acute Ischemic Stroke

You’ll hear buzz about the thrombolytic tenecteplase (TNKase) now that it’s approved by Health Canada for treating acute ischemic stroke...

Resources

Chart: Antiplatelets for Recurrent Ischemic Stroke

Set the Record Straight With Menopausal Hormone Therapy

Patients will ask you about menopausal hormone therapy (MHT)...

Know What's New With Sublocade for Opioid Use Disorder

Buprenorphine inj (Sublocade) is easier to give, now that it can be started by “rapid induction” and administered SC at new injection sites...

Clear the Air With New COPD Guidelines

Patients with COPD will start daily inhalers sooner...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Communicating With Empathy

CE-IN-THE-LETTER: Pharmacist's Letter Canada February 2026

LIVE CE: Pharmacy Essential Updates February 2026

PODCAST CE: Medication Talk - Smoking and Vaping Cessation

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information